Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for mammalian cell banking. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Mammalian Cell Banking Market Size (2024E): USD 496.5 Million
• Projected Market Value (2033F): USD 1600 Million
• Global Market Growth Rate (CAGR 2024 to 2033): 13.9%

Mammalian Cell Banking Market - Report Scope:

Mammalian cell banking plays a crucial role in biopharmaceutical and biotechnology industries, providing a stable repository of cell lines for various applications, including drug development, vaccine production, and regenerative medicine. The market serves pharmaceutical companies, academic institutions, research laboratories, and contract research organizations (CROs), offering a range of services such as cell line characterization, storage, and distribution.

Market Growth Drivers:

The global mammalian cell banking market is driven by several key factors, including the increasing demand for biopharmaceuticals, rising investments in cell-based therapies, and advancements in biotechnology that enhance cell line stability and productivity. The growing prevalence of chronic diseases and the need for efficient production of biologics further propel market expansion. Moreover, technological innovations in cryopreservation techniques and quality control measures contribute to market growth by ensuring the integrity and viability of stored cell lines.

Market Restraints:

Despite promising growth prospects, the mammalian cell banking market faces challenges related to regulatory compliance, ethical considerations in cell line sourcing, and the complexity of maintaining cell line authenticity and purity over extended storage periods. Stringent regulations governing cell banking practices and the need for continuous monitoring to prevent contamination impose operational challenges on market players, affecting scalability and cost-efficiency.

Market Opportunities:
The mammalian cell banking market presents significant growth opportunities driven by emerging applications in personalized medicine, cell therapy, and stem cell research. The integration of automation and robotics in cell banking facilities enhances operational efficiency and reduces human error, thereby optimizing cell line management and storage. Furthermore, strategic collaborations between biopharmaceutical companies, academic institutions, and CROs facilitate knowledge exchange and accelerate innovation in cell banking technologies.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the mammalian cell banking market globally?
• Which applications and therapeutic areas are driving demand for mammalian cell banking services?
• How are technological advancements reshaping the competitive landscape of the mammalian cell banking market?
• Who are the key players contributing to the mammalian cell banking market, and what strategies are they employing to maintain market leadership?
• What are the emerging trends and future prospects in the global mammalian cell banking market?

Competitive Intelligence and Business Strategy:

Leading players in the global mammalian cell banking market, including Merck KGaA, Altogen Labs, and VIRUSURE, focus on innovation, expansion of service portfolios, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced cell banking solutions, including automated cryopreservation systems, cell line authentication technologies, and personalized medicine applications. Collaborations with regulatory agencies and industry stakeholders promote compliance with international quality standards and facilitate market access.

Key Companies Profiled:

• Eurofins DiscoverX Corporation
• Merck KGaA
• Sartorius Stedim BioOutsource Limited.
• Charles River Laboratories
• Altogen Labs
• Abzena Ltd
• Northway Biotechpharma
• Lonza Group Ltd
• VIRUSURE
• Selexis SA
• Takara Bio Inc

Key Segments Covered in Manufacturing of Industry Research

Cell Type:
• CHO
• BHK
• NS0
• YB2/0 & P2/0
• HEK293 & Derivatives
• HELA

Technology:
• TEP
• IEP
• SEP

Application:
• MCB
• WCB
• EoP
• R&D CB

End User:
• Academic & Research Institute
• Biopharmaceutical Companies
• CROs

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East & Africa (MEA)

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Key Success Factors
4.1. Pipeline Assessment
4.2. Value chain Analysis
4.3. Key Promotional Strategies, By Key Manufacturers
4.4. Regulatory Landscape
4.5. PESTLE Analysis
4.6. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.1.3. Global Cell Banking Outsourcing Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Market Consolidation Activities
5.2.3. Increasing Geriatric Population
5.2.4. Rising Cases of Cancer
5.2.5. Growing Preference of Mammalian Cell Banking
5.2.6. Increased R&D investments by Government
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis – Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Cell
6.1.2. By Technology
6.1.3. By Application
6.1.4. By End User
6.1.5. By Region
6.2. 2024 Market Scenario
7. Global Mammalian Cell Banking Market Demand Value or Size in (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Cell
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2024-2033
8.3.1. CHO
8.3.2. BHK
8.3.3. NS0
8.3.4. YB2/0 & P2/0
8.3.5. HEK293 & Derivatives
8.3.6. HELA
8.4. Market Attractiveness Analysis By Cell
9. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Technology
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Technology, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2024-2033
9.3.1. TEP
9.3.2. IEP
9.3.3. SEP
9.4. Market Attractiveness Analysis By Technology
10. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
10.3.1. MCB
10.3.2. WCB
10.3.3. EoP
10.3.4. R&D CB
10.4. Market Attractiveness Analysis By Application
11. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By End User, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
11.3.1. Academic & Research Institute
11.3.2. Biopharmaceutical Companies
11.3.3. CROs
11.4. Market Attractiveness Analysis By End User
12. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Cell
13.3.3. By Technology
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Cell
13.4.3. By Technology
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. U.S. Mammalian Cell Banking Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Cell
13.8.1.2.2. By Technology
13.8.1.2.3. By Application
13.8.1.2.4. By End User
13.8.2. Canada Mammalian Cell Banking Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Cell
13.8.2.2.2. By Technology
13.8.2.2.3. By Application
13.8.2.2.4. By End User
14. Latin America Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Mexico
14.3.1.2. Brazil
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Cell
14.3.3. By Technology
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Cell
14.4.3. By Technology
14.4.4. By Application
14.4.5. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Mexico Mammalian Cell Banking Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Cell
14.8.1.2.2. By Technology
14.8.1.2.3. By Application
14.8.1.2.4. By End User
14.8.2. Brazil Mammalian Cell Banking Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Cell
14.8.2.2.2. By Technology
14.8.2.2.3. By Application
14.8.2.2.4. By End User
14.8.3. Argentina Mammalian Cell Banking Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Cell
14.8.3.2.2. By Technology
14.8.3.2.3. By Application
14.8.3.2.4. By End User
15. Europe Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Italy
15.3.1.2. Germany
15.3.1.3. U.K
15.3.1.4. France
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Nordic Countries
15.3.1.8. Russia
15.3.1.9. Rest of Europe
15.3.2. By Cell
15.3.3. By Technology
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Cell
15.4.3. By Technology
15.4.4. By Application
15.4.5. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Italy Mammalian Cell Banking Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Cell
15.8.1.2.2. By Technology
15.8.1.2.3. By Application
15.8.1.2.4. By End User
15.8.2. Germany Mammalian Cell Banking Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Cell
15.8.2.2.2. By Technology
15.8.2.2.3. By Application
15.8.2.2.4. By End User
15.8.3. U.K. Mammalian Cell Banking Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Cell
15.8.3.2.2. By Technology
15.8.3.2.3. By Application
15.8.3.2.4. By End User
15.8.4. France Mammalian Cell Banking Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Cell
15.8.4.2.2. By Technology
15.8.4.2.3. By Application
15.8.4.2.4. By End User
15.8.5. Spain Mammalian Cell Banking Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Cell
15.8.5.2.2. By Technology
15.8.5.2.3. By Application
15.8.5.2.4. By End User
15.8.6. BENELUX Mammalian Cell Banking Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Cell
15.8.6.2.2. By Technology
15.8.6.2.3. By Application
15.8.6.2.4. By End User
15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Cell
15.8.7.2.2. By Technology
15.8.7.2.3. By Application
15.8.7.2.4. By End User
15.8.8. Russia Mammalian Cell Banking Market Analysis
15.8.8.1. Introduction
15.8.8.2. Market Analysis and Forecast by Market Taxonomy
15.8.8.2.1. By Cell
15.8.8.2.2. By Technology
15.8.8.2.3. By Application
15.8.8.2.4. By End User
16. South Asia Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Cell
16.3.3. By Technology
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Cell
16.4.3. By Technology
16.4.4. By Application
16.4.5. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Mammalian Cell Banking Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Cell
16.8.1.2.2. By Technology
16.8.1.2.3. By Application
16.8.1.2.4. By End User
16.8.2. Indonesia Mammalian Cell Banking Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Cell
16.8.2.2.2. By Technology
16.8.2.2.3. By Application
16.8.2.2.4. By End User
16.8.3. Malaysia Mammalian Cell Banking Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Cell
16.8.3.2.2. By Technology
16.8.3.2.3. By Application
16.8.3.2.4. By End User
16.8.4. Thailand Mammalian Cell Banking Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Cell
16.8.4.2.2. By Technology
16.8.4.2.3. By Application
16.8.4.2.4. By End User
17. East Asia Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Cell
17.3.3. By Technology
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Cell
17.4.3. By Technology
17.4.4. By Application
17.4.5. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. China Mammalian Cell Banking Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Cell
17.8.1.2.2. By Technology
17.8.1.2.3. By Application
17.8.1.2.4. By End User
17.8.2. Japan Mammalian Cell Banking Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Cell
17.8.2.2.2. By Technology
17.8.2.2.3. By Application
17.8.2.2.4. By End User
17.8.3. South Korea Mammalian Cell Banking Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Cell
17.8.3.2.2. By Technology
17.8.3.2.3. By Application
17.8.3.2.4. By End User
18. Oceania Mammalian Cell Banking Market 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Cell
18.3.3. By Technology
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Cell
18.4.3. By Technology
18.4.4. By Application
18.4.5. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. Australia Mammalian Cell Banking Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Cell
18.8.1.2.2. By Technology
18.8.1.2.3. By Application
18.8.1.2.4. By End User
18.8.2. New Zealand Mammalian Cell Banking Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Cell
18.8.2.2.2. By Technology
18.8.2.2.3. By Application
18.8.2.2.4. By End User
19. Middle East and Africa (MEA) Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. North Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Cell
19.3.3. By Technology
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Cell
19.4.3. By Technology
19.4.4. By Application
19.4.5. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Cell
19.8.1.2.2. By Technology
19.8.1.2.3. By Application
19.8.1.2.4. By End User
19.8.2. Turkey Mammalian Cell Banking Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Cell
19.8.2.2.2. By Technology
19.8.2.2.3. By Application
19.8.2.2.4. By End User
19.8.3. South Africa Mammalian Cell Banking Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Cell
19.8.3.2.2. By Technology
19.8.3.2.3. By Application
19.8.3.2.4. By End User
19.8.4. North Africa Mammalian Cell Banking Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Cell
19.8.4.2.2. By Technology
19.8.4.2.3. By Application
19.8.4.2.4. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Presence Analysis
20.3.1. By Regional Footprint of Players
20.3.2. Cell Footprint of Players
20.3.3. Channel Footprint of Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Eurofins DiscoverX Corporation
21.3.1.1. Overview
21.3.1.2. Product & Services Portfolio
21.3.1.3. Key Financials
21.3.1.4. SWOT Analysis
21.3.1.5. Key Developments
21.3.1.6. Sales Footprint
21.3.1.7. Strategy Overview
21.3.1.7.1. Marketing Strategy
21.3.1.7.2. Product Strategy
21.3.1.7.3. Channel Strategy
21.3.2. Merck KGaA
21.3.2.1. Overview
21.3.2.2. Product & Services Portfolio
21.3.2.3. Key Financials
21.3.2.4. SWOT Analysis
21.3.2.5. Key Developments
21.3.2.6. Sales Footprint
21.3.2.7. Strategy Overview
21.3.2.7.1. Marketing Strategy
21.3.2.7.2. Product Strategy
21.3.2.7.3. Channel Strategy
21.3.3. Sartorius Stedim BioOutsource Limited.
21.3.3.1. Overview
21.3.3.2. Product & Services Portfolio
21.3.3.3. Key Financials
21.3.3.4. SWOT Analysis
21.3.3.5. Key Developments
21.3.3.6. Sales Footprint
21.3.3.7. Strategy Overview
21.3.3.7.1. Marketing Strategy
21.3.3.7.2. Product Strategy
21.3.3.7.3. Channel Strategy
21.3.4. Charles River Laboratories
21.3.4.1. Overview
21.3.4.2. Product & Services Portfolio
21.3.4.3. Key Financials
21.3.4.4. SWOT Analysis
21.3.4.5. Key Developments
21.3.4.6. Sales Footprint
21.3.4.7. Strategy Overview
21.3.4.7.1. Marketing Strategy
21.3.4.7.2. Product Strategy
21.3.4.7.3. Channel Strategy
21.3.5. Altogen Labs
21.3.5.1. Overview
21.3.5.2. Product & Services Portfolio
21.3.5.3. Key Financials
21.3.5.4. SWOT Analysis
21.3.5.5. Key Developments
21.3.5.6. Sales Footprint
21.3.5.7. Strategy Overview
21.3.5.7.1. Marketing Strategy
21.3.5.7.2. Product Strategy
21.3.5.7.3. Channel Strategy
21.3.6. Abzena Ltd
21.3.6.1. Overview
21.3.6.2. Product & Services Portfolio
21.3.6.3. Key Financials
21.3.6.4. SWOT Analysis
21.3.6.5. Key Developments
21.3.6.6. Sales Footprint
21.3.6.7. Strategy Overview
21.3.6.7.1. Marketing Strategy
21.3.6.7.2. Product Strategy
21.3.6.7.3. Channel Strategy
21.3.7. Northway Biotechpharma
21.3.7.1. Overview
21.3.7.2. Product & Services Portfolio
21.3.7.3. Key Financials
21.3.7.4. SWOT Analysis
21.3.7.5. Key Developments
21.3.7.6. Sales Footprint
21.3.7.7. Strategy Overview
21.3.7.7.1. Marketing Strategy
21.3.7.7.2. Product Strategy
21.3.7.7.3. Channel Strategy
21.3.8. Lonza Group Ltd
21.3.8.1. Overview
21.3.8.2. Product & Services Portfolio
21.3.8.3. Key Financials
21.3.8.4. SWOT Analysis
21.3.8.5. Key Developments
21.3.8.6. Sales Footprint
21.3.8.7. Strategy Overview
21.3.8.7.1. Marketing Strategy
21.3.8.7.2. Product Strategy
21.3.8.7.3. Channel Strategy
21.3.9. VIRUSURE
21.3.9.1. Overview
21.3.9.2. Product & Services Portfolio
21.3.9.3. Key Financials
21.3.9.4. SWOT Analysis
21.3.9.5. Key Developments
21.3.9.6. Sales Footprint
21.3.9.7. Strategy Overview
21.3.9.7.1. Marketing Strategy
21.3.9.7.2. Product Strategy
21.3.9.7.3. Channel Strategy
21.3.10. Selexis SA
21.3.10.1. Overview
21.3.10.2. Product & Services Portfolio
21.3.10.3. Key Financials
21.3.10.4. SWOT Analysis
21.3.10.5. Key Developments
21.3.10.6. Sales Footprint
21.3.10.7. Strategy Overview
21.3.10.7.1. Marketing Strategy
21.3.10.7.2. Product Strategy
21.3.10.7.3. Channel Strategy
21.3.11. Sigma-Aldrich
21.3.11.1. Overview
21.3.11.2. Product & Services Portfolio
21.3.11.3. Key Financials
21.3.11.4. SWOT Analysis
21.3.11.5. Key Developments
21.3.11.6. Sales Footprint
21.3.11.7. Strategy Overview
21.3.11.7.1. Marketing Strategy
21.3.11.7.2. Product Strategy
21.3.11.7.3. Channel Strategy
21.3.12. Takara Bio Inc
21.3.12.1. Overview
21.3.12.2. Product & Services Portfolio
21.3.12.3. Key Financials
21.3.12.4. SWOT Analysis
21.3.12.5. Key Developments
21.3.12.6. Sales Footprint
21.3.12.7. Strategy Overview
21.3.12.7.1. Marketing Strategy
21.3.12.7.2. Product Strategy
21.3.12.7.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology